International Journal of Cancer Management

Published by: Kowsar

Clinical Outcome and Prognostic Factors for Very Young Patients with Breast Cancer: A Comparative Matched Single Institution Study in Iran

Afshin Rakhsha 1 , Amir Anvari 2 , Abolfazl Razzaghdoust 3 and Amir Shahram Yousefi Kashi 1 , *
Authors Information
1 Cancer Research Center, Faculty of Medicine, Shahid Beheshti Univeristy of Medical Sciences, Tehran, IR Iran
2 Department of Radiation Oncology, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Urology and Nephrology Research Center, Department of Radiation Oncology, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of Cancer Management: September 2017, 10 (9); e11772
  • Published Online: September 30, 2017
  • Article Type: Research Article
  • Received: April 15, 2016
  • Revised: April 23, 2017
  • Accepted: September 29, 2017
  • DOI: 10.5812/ijcm.11772

To Cite: Rakhsha A, Anvari A, Razzaghdoust A, Yousefi Kashi A S. Clinical Outcome and Prognostic Factors for Very Young Patients with Breast Cancer: A Comparative Matched Single Institution Study in Iran, Int J Cancer Manag. 2017 ; 10(9):e11772. doi: 10.5812/ijcm.11772.

Abstract
Copyright © 2017, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5): 359-86[DOI][PubMed]
  • 2. Yavari P, Hislop TG, Bajdik C, Sadjadi A, Nouraie M, Babai M, et al. Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev. 2006; 7(1): 86-90[PubMed]
  • 3. Harold J, Burstein JRH, Morrow M. Cancer: Principles and practice of oncology. 2011; : 1401-46
  • 4. Madaras L, Baranyak Z, Kulka J, Szasz AM, Kovacs A, Lan PH, et al. Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients. Pathol Oncol Res. 2013; 19(4): 723-9[DOI][PubMed]
  • 5. Winchester DP. Breast cancer in young women. Surg Clin North Am. 1996; 76(2): 279-87[PubMed]
  • 6. Han W, Kim SW, Park IA, Kang D, Kim SW, Youn YK, et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer. 2004; 4: 82[DOI][PubMed]
  • 7. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007; 109(9): 1721-8[DOI][PubMed]
  • 8. Rakhsha A, Yousefi Kashi AS, Hoseini SM. Evaluation of Survival and Treatment Toxicity With High-Dose-Rate Brachytherapy With Cobalt 60 in Carcinoma of Cervix. Iran J Cancer Prev. 2015; 8(4): 3573[DOI][PubMed]
  • 9. Gajdos C, Tartter PI, Bleiweiss IJ, Bodian C, Brower ST. Stage 0 to stage III breast cancer in young women. J Am Coll Surg. 2000; 190(5): 523-9[PubMed]
  • 10. Meng J, Lang RG, Fan Y, Fu L. [Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis]. Zhonghua Zhong Liu Za Zhi. 2007; 29(4): 284-8[PubMed]
  • 11. Wei XQ, Li X, Xin XJ, Tong ZS, Zhang S. Clinical features and survival analysis of very young (age<35) breast cancer patients. Asian Pac J Cancer Prev. 2013; 14(10): 5949-52[PubMed]
  • 12. Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko SS, et al. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society. J Clin Oncol. 2007; 25(17): 2360-8[DOI][PubMed]
  • 13. Kothari AS, Beechey-Newman N, D'Arrigo C, Hanby AM, Ryder K, Hamed H, et al. Breast carcinoma in women age 25 years or less. Cancer. 2002; 94(3): 606-14[PubMed]
  • 14. Chung M, Chang HR, Bland KI, Wanebo HJ. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996; 77(1): 97-103[DOI][PubMed]
  • 15. Yousefi Kashi ASH, Mofid B, Mirzaei HR, Azadeh P. Overall survival and related prognostic factors in metastatic brain tumor treated with whole brain radiation therapy. J Res Med Sci. 2010; 4: 213-6
  • 16. Muscolino G, Villani C, Bedini AV, Luini A, Salvadori B. Young age is not an ominous prognostic factor in breast cancer patients. Tumori. 1987; 73(3): 233-5[PubMed]
  • 17. Yousefi Kashi ASH, Yazdanfar SH, Akbari ME, Rakhsha A. Triple Negative Breast Cancer in Iranian Women: Clinical Profile and Survival Study. Iran J Cancer Prev 2017; 10(7)[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments